ShiononeCAS# 10376-48-4 |
2D Structure
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 10376-48-4 | SDF | Download SDF |
PubChem ID | 122861 | Appearance | Powder |
Formula | C30H50O | M.Wt | 426.72 |
Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | (1R,4bS,6aS,8R,10aR,12aS)-1,4b,6a,8,10a,12a-hexamethyl-8-(4-methylpent-3-enyl)-1,3,4,4a,5,6,7,9,10,10b,11,12-dodecahydrochrysen-2-one | ||
SMILES | CC1C(=O)CCC2C1(CCC3C2(CCC4(C3(CCC(C4)(C)CCC=C(C)C)C)C)C)C | ||
Standard InChIKey | HXPXUNQUXCHJLL-PYOYDRRISA-N | ||
Standard InChI | InChI=1S/C30H50O/c1-21(2)10-9-14-26(4)16-19-30(8)25-13-15-28(6)22(3)23(31)11-12-24(28)29(25,7)18-17-27(30,5)20-26/h10,22,24-25H,9,11-20H2,1-8H3/t22-,24?,25?,26+,27-,28+,29-,30+/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Shionone has anti-inflammatory effect, the mechanism is related to decrease the phosphorylation level of ERK1/2 protein and IκBα and the protein expression of i NOS. It can inhibit the activity of ubiquitin-specific protease 2 (USP2) and provide a lead compound for future development of new USP2 inhibitors. |
Targets | ERK | IkB | NOS | IKK |
In vitro | Study on anti-inflammatory mechanism of shionone based on NF-κB pathway in vitro.[Reference: WebLink]China Journal of Traditional Chinese Medicine & Pharmacy, 2016(4):1430-3.To explore anti-inflammatory effect and mechanism of Shionone in vitro. |
In vivo | Expectorant, antitussive, anti-inflammatory activities and compositional analysis of Aster tataricu[Pubmed: 25701752]J Ethnopharmacol. 2015 Apr 22;164:328-33.The root of Aster tataricus L. f., recorded in all versions of Chinese Pharmacopoeia, is a traditional Chinese medicine with the function of dispelling phlegm and relieving cough for more than 2000 years. This study was designed to evaluate the expectorant, antitussive, and anti-inflammatory activities of the root of A. tataricus and to explore the chemical substances responsible for these activities.
|
Kinase Assay | Inhibitory effect of shionone on activity of ubiquitin-specific protease 2[Reference: WebLink]Journal of Shanghai Jiaotong University, 2014, 34(11):1563-7.To identify new ubiquitin-specific protease 2 (USP2) inhibitors from natural compounds.
|
Structure Identification | Zhongguo Zhong Yao Za Zhi. 2003 Aug;28(8):738-40.[Determination of shionone in Radix Asteris by HPLC].[Pubmed: 15015355]To determine the content of Shionone in Radix Aster from several different locations and markets.
|
Shionone Dilution Calculator
Shionone Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.3435 mL | 11.7173 mL | 23.4346 mL | 46.8691 mL | 58.5864 mL |
5 mM | 0.4687 mL | 2.3435 mL | 4.6869 mL | 9.3738 mL | 11.7173 mL |
10 mM | 0.2343 mL | 1.1717 mL | 2.3435 mL | 4.6869 mL | 5.8586 mL |
50 mM | 0.0469 mL | 0.2343 mL | 0.4687 mL | 0.9374 mL | 1.1717 mL |
100 mM | 0.0234 mL | 0.1172 mL | 0.2343 mL | 0.4687 mL | 0.5859 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Fasudil
Catalog No.:BCC5262
CAS No.:103745-39-7
- Rehmaglutin D
Catalog No.:BCN5851
CAS No.:103744-84-9
- YK-4-279
Catalog No.:BCC2065
CAS No.:1037184-44-3
- Dihydrobonducellin
Catalog No.:BCN3731
CAS No.:103680-87-1
- Mirificin
Catalog No.:BCN2783
CAS No.:103654-50-8
- 2-Carbamoyl-3-hydroxy-1,4-naphthoquinone
Catalog No.:BCC8567
CAS No.:103646-20-4
- Ondansetron hydrochloride dihydrate
Catalog No.:BCC4213
CAS No.:103639-04-9
- Catechin 3-rhamnoside
Catalog No.:BCN5850
CAS No.:103630-03-1
- Cnidimol A
Catalog No.:BCN7167
CAS No.:103629-80-7
- Sumatriptan Succinate
Catalog No.:BCC2502
CAS No.:103628-48-4
- Sumatriptan
Catalog No.:BCC5645
CAS No.:103628-46-2
- (±)-5'-Chloro-5'-deoxy-ENBA
Catalog No.:BCC7716
CAS No.:103626-26-2
- R428
Catalog No.:BCC3692
CAS No.:1037624-75-1
- Gimeracil
Catalog No.:BCC2296
CAS No.:103766-25-2
- Ganoderic acid C2
Catalog No.:BCN3036
CAS No.:103773-62-2
- MBX-2982
Catalog No.:BCC1732
CAS No.:1037792-44-1
- KX2-391 dihydrochloride
Catalog No.:BCC1686
CAS No.:1038395-65-1
- 7-Prenylumbelliferone
Catalog No.:BCN2938
CAS No.:10387-50-5
- 4'-O-Methyllicoflavanone
Catalog No.:BCN4827
CAS No.:1038753-13-7
- Lazabemide hydrochloride
Catalog No.:BCC7371
CAS No.:103878-83-7
- Cycloart-25-ene-3,24-diol
Catalog No.:BCN5852
CAS No.:10388-48-4
- Procyanidin A1
Catalog No.:BCN6809
CAS No.:103883-03-0
- Lacidipine
Catalog No.:BCC4403
CAS No.:103890-78-4
- MK-4827
Catalog No.:BCC1761
CAS No.:1038915-60-4
[Determination of shionone in Radix Asteris by HPLC].[Pubmed:15015355]
Zhongguo Zhong Yao Za Zhi. 2003 Aug;28(8):738-40.
OBJECTIVE: To determine the content of Shionone in Radix Aster from several different locations and markets. METHOD: The HPLC analysis was used to determine Shionone directly, using Polaris C18 column and acetonitrile as the mobile phase with a flow rate of 1.0 mL.min-1, and the UV detection wavelength was 200 nm. RESULT AND CONCLUSION: The content of Shionone was from 0.06% to 0.18%, depending on different locations and markets.
Expectorant, antitussive, anti-inflammatory activities and compositional analysis of Aster tataricus.[Pubmed:25701752]
J Ethnopharmacol. 2015 Apr 22;164:328-33.
ETHNOPHARMACOLOGICAL RELEVANCE: The root of Aster tataricus L. f., recorded in all versions of Chinese Pharmacopoeia, is a traditional Chinese medicine with the function of dispelling phlegm and relieving cough for more than 2000 years. This study was designed to evaluate the expectorant, antitussive, and anti-inflammatory activities of the root of A. tataricus and to explore the chemical substances responsible for these activities. MATERIALS AND METHODS: The 70% ethanol extract of the root of A. tataricus (RA-70) was divided into three fractions, Fr-0, Fr-50 and Fr-95. They were all orally administrated to the mice to investigate their potential expectorant activities by a tracheal phenol red secretion method. The most effective fraction, together with Shionone, was evaluated the expectorant, antitussive and anti-inflammatory activities by the mouse models of phenol red secretion, ammonia-induced cough, and xylene-induced ear swelling. Furthermore, the chemical components of the effective fraction were analyzed and identified by an HPLC-Q-TOF/MS method. RESULTS: Treatment with RA-70, Fr-0 and Fr-50 increased the amount of phenol red secretion by 65.3%, 56.5%, and 76.9%, respectively. Fr-50 was chosen for the further investigation and the results showed that Fr-50 at 40, 80 mg/kg significantly enhanced the phenol red secretion of tracheas, increased the latent period and decreased the frequency of cough and inhibited the ear edema in mice. Shionone at 80 mg/kg showed the trend of enhancing sputum secreting, but had no effect on ammonia-induced cough and xylene-induced ear edema. HPLC-Q-TOF/MS analysis indicated that Fr-50 was mainly composed of 12 caffeoylquinic acids (40.8%, in relative peak area), 7 astersaponins (12.0%) and 13 astins/asterinins (pentapeptides, 26.5%). CONCLUSIONS: The root of A. tataricus has significant expectorant, antitussive and anti-inflammatory effects. Caffeoylquinic acids, astersaponins, and aster peptides, rather than Shionone, may be the main constituents responsible for the expectorant and antitussive activities of A. tataricus and act in a synergistic way.